High court sides with drugmaker in Plavix lawsuit

June 19, 2017

The Supreme Court says hundreds of out-state-residents can't sue drugmaker Bristol-Myers Squibb Co. in California state court over adverse reactions to the blood thinner Plavix.

The justices ruled 8-1 Monday that there was not a strong enough connection between the claims against the drugmaker and the company's ties to the state.

The ruling is a win for Bristol-Myers Squibb and other companies that want to avoid lawsuits in state courts seen as more favorable to plaintiffs.

The case involved 575 non-California residents who joined 86 California residents in suing the New Jersey-based company.

California's highest court ruled 4-3 that all the cases could move ahead in state court even if the specific claims were not connected to California because the company did other business in the state.

Explore further: California court sides with consumers in generic drug fight

Related Stories

California court sides with consumers in generic drug fight

May 7, 2015
In a win for consumers, the California Supreme Court ruled Thursday that settlement agreements between pharmaceutical companies that keep cheaper, generic drugs off the market may be illegal if they include excessive cash ...

Austrian court: Facebook must delete hate postings worldwide

May 8, 2017
An Austrian court has ruled that Facebook must delete hate speech postings worldwide and that Austrian law can be applied to lawsuits against the social media website.

California appeals court rejects right-to-die lawsuit

October 29, 2015
A California appeals court on Thursday rejected a lawsuit by three terminally ill patients that sought to clear the way for doctors to prescribe fatal medication to them and others like them who want the option of taking ...

Recommended for you

Cancer drugs' high prices not justified by cost of development, study contends

September 12, 2017
(HealthDay)— Excusing the sky-high price tags of many new cancer treatments, pharmaceutical companies often blame high research and development (R&D) costs.

Non-psychotropic cannabinoids show promise for pain relief

September 4, 2017
Some cancers love bone. They thrive in its nutrient-rich environment while gnawing away at the very substrate that sustains them, all the while releasing inflammatory substances that cause pain—pain so severe that opioids ...

Fentanyl drives rise in opioid-linked deaths in U.S.

August 31, 2017
(HealthDay)—Fentanyl, a synthetic narcotic, is a key player in America's continuing epidemic of opioid-related overdose deaths, two new studies report.

Eating triggers endorphin release in the brain

August 28, 2017
Finnish researchers have revealed how eating stimulates brain's endogenous opioid system to signal pleasure and satiety.

Cholesterol-lowering drugs may fight infectious disease

August 21, 2017
That statin you've been taking to lower your risk of heart attack or stroke may one day pull double duty, providing protection against a whole host of infectious diseases, including typhoid fever, chlamydia, and malaria.

Data revealed under FOI shows benefits of multiple sclerosis drug currently blocked by regulators

August 17, 2017
A drug that is blocked by the EU regulatory system has now been found to improve the quality of life of people with multiple sclerosis (MS), according to a study by Queen Mary University of London (QMUL).

0 comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.